188 related articles for article (PubMed ID: 33449291)
1. High-Dimensional Immune Monitoring for Chimeric Antigen Receptor T Cell Therapies.
Sharma S; Quinn D; Melenhorst JJ; Pruteanu-Malinici I
Curr Hematol Malig Rep; 2021 Feb; 16(1):112-116. PubMed ID: 33449291
[TBL] [Abstract][Full Text] [Related]
2. A Guide on Analyzing Flow Cytometry Data Using Clustering Methods and Nonlinear Dimensionality Reduction (tSNE or UMAP).
Ujas TA; Obregon-Perko V; Stowe AM
Methods Mol Biol; 2023; 2616():231-249. PubMed ID: 36715939
[TBL] [Abstract][Full Text] [Related]
3. Best practices for the development, analytical validation and clinical implementation of flow cytometric methods for chimeric antigen receptor T cell analyses.
Sarikonda G; Mathieu M; Natalia M; Pahuja A; Xue Q; Pierog PL; Trampont PC; Decman V; Reynolds S; Hanafi LA; Sun YS; Eck S; Hedrick MN; Stewart JJ; Tangri S; Litwin V; Dakappagari N
Cytometry B Clin Cytom; 2021 Jan; 100(1):79-91. PubMed ID: 33373096
[TBL] [Abstract][Full Text] [Related]
4. Integration, exploration, and analysis of high-dimensional single-cell cytometry data using Spectre.
Ashhurst TM; Marsh-Wakefield F; Putri GH; Spiteri AG; Shinko D; Read MN; Smith AL; King NJC
Cytometry A; 2022 Mar; 101(3):237-253. PubMed ID: 33840138
[TBL] [Abstract][Full Text] [Related]
5. A novel luciferase-based assay for the detection of Chimeric Antigen Receptors.
Gopalakrishnan R; Matta H; Choi S; Natarajan V; Prins R; Gong S; Zenunovic A; Narasappa N; Patel F; Prakash R; Chaudhary V; Sikri V; Chitnis SD; Kochegarov A; Wang D; Falat M; Kahn M; Keerthipati PS; Sharma N; Lenka J; Stieben TM; Braun J; Batra A; Purvis K; Ito K; Lee JH; Jeronimo A; Zamora HM; Membreno A; Qiu Q; Peshin S; Namburu L; Chaudhary PM
Sci Rep; 2019 Feb; 9(1):1957. PubMed ID: 30760795
[TBL] [Abstract][Full Text] [Related]
6. Measuring Chimeric Antigen Receptor T Cells (CAR T Cells) Activation by Coupling Intracellular Cytokine Staining with Flow Cytometry.
Xu C; Yin Y
Methods Mol Biol; 2020; 2108():159-165. PubMed ID: 31939179
[TBL] [Abstract][Full Text] [Related]
7. CytoML for cross-platform cytometry data sharing.
Finak G; Jiang W; Gottardo R
Cytometry A; 2018 Dec; 93(12):1189-1196. PubMed ID: 30551257
[TBL] [Abstract][Full Text] [Related]
8. ExCYT: A Graphical User Interface for Streamlining Analysis of High-Dimensional Cytometry Data.
Sidhom JW; Theodros D; Murter B; Zarif JC; Ganguly S; Pardoll DM; Baras A
J Vis Exp; 2019 Jan; (143):. PubMed ID: 30735162
[TBL] [Abstract][Full Text] [Related]
9. Generation of CAR-T Cells for Cancer Immunotherapy.
Xu Q; Harto H; Berahovich R; Xu S; Zhou H; Golubovskaya V; Wu L
Methods Mol Biol; 2019; 1884():349-360. PubMed ID: 30465215
[TBL] [Abstract][Full Text] [Related]
10. Monitoring CAR-T cell kinetics in clinical trials by multiparametric flow cytometry: Benefits and challenges.
Sarikonda G; Pahuja A; Kalfoglou C; Burns K; Nguyen K; Ch'en IL; Pollner R; Tangri S; Dakappagari N
Cytometry B Clin Cytom; 2021 Jan; 100(1):72-78. PubMed ID: 32573972
[TBL] [Abstract][Full Text] [Related]
11. Comparative exploration of multidimensional flow cytometry software: a model approach evaluating T cell polyfunctional behavior.
Spear TT; Nishimura MI; Simms PE
J Leukoc Biol; 2017 Aug; 102(2):551-561. PubMed ID: 28550117
[TBL] [Abstract][Full Text] [Related]
12. Flow cytometry and pharmacokinetics.
Lang K; Matys K; Bennett P; Kakkanaiah VN
Bioanalysis; 2021 Nov; 13(21):1645-1651. PubMed ID: 34657485
[TBL] [Abstract][Full Text] [Related]
13. Immunophenotypic Analysis of CAR-T Cells.
de Azevedo JTC; Mizukami A; Moço PD; Malmegrim KCR
Methods Mol Biol; 2020; 2086():195-201. PubMed ID: 31707677
[TBL] [Abstract][Full Text] [Related]
14. Flow cytometry bioinformatics.
O'Neill K; Aghaeepour N; Spidlen J; Brinkman R
PLoS Comput Biol; 2013; 9(12):e1003365. PubMed ID: 24363631
[TBL] [Abstract][Full Text] [Related]
15. Manufacturing Chimeric Antigen Receptor (CAR) T Cells for Adoptive Immunotherapy.
Ghassemi S; Milone MC
J Vis Exp; 2019 Dec; (154):. PubMed ID: 31904011
[TBL] [Abstract][Full Text] [Related]
16. Chimeric antigen receptor T cell targeting EGFRvIII for metastatic lung cancer therapy.
Zhang Z; Jiang J; Wu X; Zhang M; Luo D; Zhang R; Li S; He Y; Bian H; Chen Z
Front Med; 2019 Feb; 13(1):57-68. PubMed ID: 30721445
[TBL] [Abstract][Full Text] [Related]
17. Gene Modification and Immunological Analyses for the Development of Immunotherapy Utilizing T Cells Redirected with Antigen-Specific Receptors.
Ochi T; Maruta M; Hirano N
Methods Mol Biol; 2019; 2048():27-39. PubMed ID: 31396926
[TBL] [Abstract][Full Text] [Related]
18.
Opzoomer JW; Timms JA; Blighe K; Mourikis TP; Chapuis N; Bekoe R; Kareemaghay S; Nocerino P; Apollonio B; Ramsay AG; Tavassoli M; Harrison C; Ciccarelli F; Parker P; Fontenay M; Barber PR; Arnold JN; Kordasti S
Elife; 2021 Apr; 10():. PubMed ID: 33929322
[TBL] [Abstract][Full Text] [Related]
19. Optimization of manufacturing conditions for chimeric antigen receptor T cells to favor cells with a central memory phenotype.
Gargett T; Truong N; Ebert LM; Yu W; Brown MP
Cytotherapy; 2019 Jun; 21(6):593-602. PubMed ID: 30975603
[TBL] [Abstract][Full Text] [Related]
20. Chimeric antigen receptor-engineered T-cell therapy for liver cancer.
Chen Y; E CY; Gong ZW; Liu S; Wang ZX; Yang YS; Zhang XW
Hepatobiliary Pancreat Dis Int; 2018 Aug; 17(4):301-309. PubMed ID: 29861325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
